Allena Pharmaceuticals, Inc.
USD0.07
+0.00 (+3.16%)
CEO
Louis Brenner
IPO Date
2017-11-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.06
Prev. Close
$0.07
Day Low
$0.06
Day High
$0.15
Volume
252.31M
| 255,000 |
| $0.00 |
| 17 Nov 2021 | BRENNER LOUIS MD | director, officer: President and CEO | M-Exempt | Acquired | 125,582 | $0.00 |
| 17 Nov 2021 | BRENNER LOUIS MD | director, officer: President and CEO | S-Sale | Disposed | 40,328 | $0.81 |
| 17 Nov 2021 | BRENNER LOUIS MD | director, officer: President and CEO | M-Exempt | Disposed | 125,582 | $0.00 |
| 4 Jun 2021 | Diaz Allene M. | director | A-Award | Acquired | 37,000 | $1.14 |
| 4 Jun 2021 | Alexander Robert | director | A-Award | Acquired | 37,000 | $1.14 |
| 4 Jun 2021 | Miller Ann Calby | director | A-Award | Acquired | 37,000 | $1.14 |
| 4 Jun 2021 | Margolin Alexey L | director | A-Award | Acquired | 37,000 | $1.14 |
| 4 Jun 2021 | SANTINI GINO | director | A-Award | Acquired | 37,000 | $1.14 |